CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren. 74% der Privatanlegerkonten verlieren Geld, wenn sie mit diesem Anbieter CFDs handeln. Sie sollten überlegen, ob Sie wirklich verstehen, wie CFDs funktionieren, und ob Sie es sich leisten können, das hohe Risiko von finanziellen Verlusten einzugehen.

Close

Traden Amgen AMGN

Verkaufen
 Kaufen

Amgen Live-Chart

5m 15m 30m 1h 4h 1d 1w

Instrument-Grundlagen

Weekly Search
Weekly
Daily
Datum Schließen Änderung Veränderung in % Eröffnen Hoch Niedrig

Neueste Meldungen

Closing 2024
2024 Dec 26, 17:00

Wochenausblick: Jahresabschluss 2024 und erste Konjunkturdaten aus 2025

Forex Indizes
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Wochenausblick: Letzte vollständige Woche des Jahres 2024 an den Finanzmärkten

Indizes Forex
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Wochenausblick: US-Zinssatz und Inflation in Europa bestimmen die Richtung der Märkte

Forex Indizes
Dyogenes Diniz 2024 Dec 05, 16:00

Wochenausblick: Inflation und Zinssätze werden die Märkte diese Woche bewegen

Forex Indizes
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Wochenausblick:  Die US-Beschäftigung dürfte die Marktstimmung in dieser Woche bestimmen.

Forex Indizes
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Wochenausblick:  Die Inflation der Eurozone wird die EZB-Senkung im Dezember wahrscheinlich bestätigen

Forex Indizes
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Wochenausblick: Tech-Rallye hängt von Nvidia-Ergebnissen ab

Forex Indizes
Markets.com Support Team 2024 Nov 07, 16:00

Wochenausblick:  Trump-Marke, Inflationsdaten, Disney-Ergebnisse

Forex Indizes

Info

Spread

1.98

Spread (%)

0.6765 %

Hebel

1:5

Übernacht-Zinsen (Kauf)

-0.0597 %

Übernacht-Zinsen (Verkauf)

-0.0292 %

Währung

USD

Handelszeiten

Market open

Dienstag

13:31 - 19:59

Montag

13:31-19:59

Mittwoch

13:31-19:59

Donnerstag

13:31-19:59

Freitag

13:31-19:59

Analyse und Statistik

Eröffnen

---

Vorher geschlossen

---

52-Wochen-Hoch/Tief

--- – ---

Marktkapitalisierung

157895294976

Ausstehende Aktien

537204992

Quartalsdatum (Nächstes)

1999-11-22

Dividendenrendite

2025-06-06

Ex-Dividendendatum

2025-05-16

Der zukünftige jährliche Dividendensatz

9.52

Die zukünftige jährliche Dividendenrendite

0.0333

EPS

7.76

Erfahren Sie mehr über dieses Instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Ähnliche Instrumente

Basiswert
Verkaufen
Kaufen
Veränderung in %

Handeln Sie jetzt

Handeln Sie jetzt

Handeln Sie jetzt

Handeln Sie jetzt
Ähnliche Instrumente
Trustpilot
RequestMessages7TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version29.18msRequest Duration2MBMemory UsageGET csrf
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
controller_action
Closure
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/csrf
action_name
controller_action
Closure
uri
GET csrf
file
routes/web.php:26-30
middleware
web
duration
29.73ms
peak_memory
4MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktv4_ip_override=my; mktloc=eyJpdiI6IitGbmJjamlRcWhaMkY5MW1xMnk1OVE9PSIsInZhbHVlIjoiOVBLU2JpVWJyNlRPVHNHVTRFSVVjcGhRM1lvSGRFN3RwSVZ4OTJKMDRzY0pxcmtwM1IzM3NQT2UyeU5KRnlWVCIsIm1hYyI6IjcxOWVhMTA1N2MyOTM4NDYyYzJlYzhjYmM1OGVlMGY0NjYwODYyNjViZGZiNjgwMGEwZDU0NGQxNmFhMGI3MTMiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fes%252Finstrument%252Faptiv%252F; intent_instrument=aptiv; XSRF-TOKEN=eyJpdiI6IlJkbU50cmZsRDNxcEh2WFVIWlRvemc9PSIsInZhbHVlIjoibU9JRkZFZ2Z3M2E3NmovQkRUN1AxdC9ZRmpEYXpVK0xwU29VdEpEaUVISmhwT1pUamRWVDNieTg0Y2VmcW41R0RabGlsS3N6L0NEMEtUdFpjR09UcFZsbUp3MVNBaXNZNkFrdU9ISEhNYzhQUmNzU3QvS3RQN0JXNGpNaWo2aVYiLCJtYWMiOiI4ZTA3NzBiNWM5ZDRmNDAxYjU1MzdiYjM4YjE3ZWRhNTZjNTc4ZWU5ZjhlMTdlMjJjMmNlNTA1MDJkNTg5YmQ4IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6ImhRbHcrTUxXWHpnZTlVWWtobFFieEE9PSIsInZhbHVlIjoiQ2FJYWRtZi83ek9BcHgxMGxXVUJTYU1zcG1jampGYVNuRWF1Z2pNWmJYd2swd3craWo0YmxtRFl5VGFPQm5zV3JwZnkxV2dSODV3aWgyUXdRaVJTQm5kQWloTENrR29DRFVZRGFqdXladTVtTGQ2dUJBeHlZdENpYUE0d1VaR3ciLCJtYWMiOiI4NTUxODdhZGM5YzZkZWE4NWFlNDJjNGNjZWU0MGM4OGM1NDgyYTE3ZjM4N2MxOWZhY2Q5YWQ3MzM2NzJhOTExIiwidGFnIjoiIn0%3D ◀mktv4_ip_override=my; mktloc=eyJpdiI6IitGbmJjamlRcWhaMkY5MW1xMnk1OVE9PSIsInZhbHVlIjoiOVBLU2JpVWJyNlRPVHNHVTRFSVVjcGhRM1lvSGRFN3RwSVZ4OTJKMDRzY0pxcmtwM1IzM3NQT2U ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:6 [▼
  "mktv4_ip_override" => null
  "mktloc" => "us,us"
  "intent_group" => null
  "intent_instrument" => null
  "XSRF-TOKEN" => "aeiKrstcV4xZH1lXQwrg3GSVpNADkU6c9BiD6G6K"
  "laravel_session" => "M9c6ys5iHfYU6DBBGQT7s21sRElPQLfkrGAIDxKU"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Tue, 15 Apr 2025 18:51:28 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "aeiKrstcV4xZH1lXQwrg3GSVpNADkU6c9BiD6G6K"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/es/APTV:NYSE?scheme=light"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (9.14ms)time
    • Application (20.03ms)time
    • Routing (466μs)
    • 1 x Application (68.64%)
      20.03ms
      1 x Booting (31.33%)
      9.14ms
      1 x Routing (1.6%)
      466μs
      0 templates were rendered
        uri
        GET csrf
        middleware
        web
        uses
        Closure(Request $request) {#347 class: "Illuminate\Routing\RouteFileRegistrar" this: Illuminate\Routing\RouteFileRegistrar {#344 …} file: "/var/www/website/qa/laravel/routes/web.php" line: "26 to 30" }
        file
        routes/web.php:26-30
        0 statements were executed0μs
              _token
              aeiKrstcV4xZH1lXQwrg3GSVpNADkU6c9BiD6G6K
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/widget/tradingcentralinfo/es/APTV:NYSE?sche...
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-15 18:51:25GET/de/instrument/amgen/767
              #22025-04-15 18:51:28GET/params/ (ajax)
              #32025-04-15 18:51:28GET/csrf/ (ajax)